Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer

References

• KitaharaCMSosaJAThe changing incidence of thyroid cancerNat Rev Endocrinol2016121164665327418023
   PubMed Web of Science ®Google Scholar
• SiposJAMazzaferriELThyroid cancer epidemiology and prognostic variablesClin Oncol (R Coll Radiol)201022639540420627675
   PubMed Web of Science ®Google Scholar
• SchlumbergerMCatargiBBorgetIStrategies of radioiodine ablation in patients with low-risk thyroid cancerN Engl J Med2012366181663167322551127
   PubMed Web of Science ®Google Scholar
• MallickUHarmerCYapBAblation with low-dose radioiodine and thyrotropin alfa in thyroid cancerN Engl J Med2012366181674168522551128
   PubMed Web of Science ®Google Scholar
• HanJMKimWGKimTYEffects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extensionThyroid201452482082524328997
   PubMedGoogle Scholar
• SongXMengZJiaQDifferent radioiodine dose for remnant thyroid ablation in patients with differentiated thyroid cancer: a meta-analysisClin Nucl Med2015401077477926204220
   PubMedGoogle Scholar
• CeccarelliCBencivelliWMorcianoDPincheraAPaciniF131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective studyJ Clin Endocrinol Metab20018683512351511502772
   PubMedGoogle Scholar
• TsangRWBrierleyJDSimpsonWJPanzarellaTGospodarowiczMKSutcliffeSBThe effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinomaCancer19988223753889445196
   PubMed Web of Science ®Google Scholar
• MazzaferriELKloosRTClinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancerJ Clin Endocrinol Metab20018641447146311297567
   PubMed Web of Science ®Google Scholar
• SawkaAMBrierleyJDTsangRWAn updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancerEndocrinol Metab Clin North Am200837245748018502337
   PubMed Web of Science ®Google Scholar
• HaugenBRAlexanderEKBibleKC2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancerThyroid2016261113326462967
   PubMed Web of Science ®Google Scholar
• VerburgFAAktolunCChitiAWhy the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancerEur J Nucl Med Mol Imaging20164361001100526883666
   PubMed Web of Science ®Google Scholar
• QuYHuangRLiLLow- and high-dose radioiodine therapy for low-/intermediate-risk differentiated thyroid cancer: a preliminary clinical trialAnn Nucl Med2016311718327757803
   PubMedGoogle Scholar
• PaciniFSchlumbergerMDralleHEliseiRSmitJWWiersingaWEuropean Thyroid Cancer TaskforceEuropean consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEur J Endocrinol2006154678780316728537
   PubMed Web of Science ®Google Scholar
• SawkaAMThephamongkholKBrouwersMThabaneLBrowmanGGersteinHCClinical review 170: a systematic review and meta analysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancerJ Clin Endocrinol Metab20048983668367615292285
   PubMed Web of Science ®Google Scholar
• HackshawAHarmerCMallickUHaqMFranklynJA131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic reviewJ Clin Endocrinol Metab2007921283817032718
   PubMedGoogle Scholar
• McCowenKDAdlerRAGhaedNVerdonTHofeldtFDLow dose radioiodide thyroid ablation in postsurgical patients with thyroid cancerAm J Med19766115258937370
   PubMedGoogle Scholar
• SiddiquiAREdmondsonJWellmanHNFeasibility of low doses of 131I for thyroid ablation in postsurgical patients with thyroid carcinomaClin Nucl Med1981641581617214770
   PubMedGoogle Scholar
• DoiSAWoodhouseNJAblation of the thyroid remnant and 131I dose in differentiated thyroid cancerClin Endocrinol (Oxf)2000526765773
   Web of Science ®Google Scholar
• KukulskaAKrajewskaJGawkowska-SuwinskaMRadioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCiThyroid Res201031921040579
   PubMedGoogle Scholar
• MaenpaaHOHeikkonenJVaalavirtaLTenhunenMJoensuuHLow vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized studyPLoS One200834e188518382668
   PubMed Web of Science ®Google Scholar
• JohansenKWoodhouseNJOdugbesanOComparison of 1073 and 3700MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancerJ Nucl Med19913222522541992028
   PubMedGoogle Scholar
• TaubeALundellGProspective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinomaCancer19977911901918988747
   PubMedGoogle Scholar
• FallahiBBeikiDTakavarALow versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trialNucl Med Commun201233327528222124360
   PubMedGoogle Scholar
• WartofskyLVan NostrandDRadioiodine treatment of well-differentiated thyroid cancerEndocrine201242350651322733393
   PubMed Web of Science ®Google Scholar